High levels of LincIN expression are significantly associated with advanced breast cancer, and analysis of a large TCGA cohort suggested that LincIN is a promising prognostic biomarker for breast cancer (Fig. 2 and Table 1). This evidence concerns the gene ITGB1-DT and breast carcinoma.